erlotinib hydrochloride has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KI; Bailey, J; Baldock, PA; Boulghourjian, A; Chtanova, T; Conway, JRW; Croucher, PI; Del Monte-Nieto, G; Gallego-Ortega, D; Grey, ST; Gunning, PW; Hardeman, EC; Harvey, RP; Herrmann, D; Herzog, H; Johnsson, AE; Kadir, S; Killen, M; Law, AM; Leung, W; Lucas, MC; Magenau, A; Masedunskas, A; McGhee, EJ; Morton, JP; Mrowinska, A; Nobis, M; Ormandy, CJ; Pajic, M; Quinn, JMW; Reischmann, N; Samuel, MS; Sansom, OJ; Schwarz, JP; Stevenson, D; Strathdee, D; Timpson, P; Vennin, C; Walters, SN; Warren, SC; Welch, HCE; Zaratzian, A; Zhang, L | 1 |
| Burga, LN; Hofstatter, EW; Hu, H; Juvekar, A; Troyan, SL; Tung, NM; Wulf, GM | 1 |
| Arteaga, CL; Caldwell, RL; Caprioli, RM; Dugger, TC; Forbes, JT; Guix, M; Reyzer, ML; Ritter, CA | 1 |
3 other study(ies) available for erlotinib hydrochloride and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts.
Topics: Animals; Antineoplastic Agents; Biosensing Techniques; Bone and Bones; Cell Movement; Dasatinib; Erlotinib Hydrochloride; Female; Fluorescence Resonance Energy Transfer; Gene Expression Regulation; Intestine, Small; Intravital Microscopy; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mechanotransduction, Cellular; Mice; Mice, Transgenic; Neutrophils; Osteocytes; Pancreatic Neoplasms; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Time-Lapse Imaging | 2017 |
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Topics: Aldehyde Dehydrogenase 1 Family; Animals; BRCA1 Protein; Breast; Cell Line, Tumor; Cell Transformation, Neoplastic; Cells, Cultured; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Erlotinib Hydrochloride; Female; Genes, BRCA1; Genes, p53; Humans; Isoenzymes; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Kinase Inhibitors; Quinazolines; Receptors, Estrogen; Retinal Dehydrogenase; RNA Interference | 2011 |
Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Molecular Sequence Data; Predictive Value of Tests; Protein Kinase Inhibitors; Proteome; Quinazolines; Receptor, ErbB-2; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trastuzumab | 2004 |